The Clorox Company (NYSE:CLX) Shares Sold by Gulf International Bank UK Ltd

Gulf International Bank UK Ltd lowered its holdings in The Clorox Company (NYSE:CLX) by 0.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,670 shares of the company’s stock after selling 83 shares during the period. Gulf International Bank UK Ltd’s holdings in Clorox were worth $1,570,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Catalyst Capital Advisors LLC acquired a new position in shares of Clorox in the 3rd quarter worth approximately $54,000. Los Angeles Capital Management LLC increased its position in shares of Clorox by 5.6% in the third quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock worth $31,266,000 after acquiring an additional 10,149 shares in the last quarter. Advisors Asset Management Inc. increased its position in shares of Clorox by 43.4% in the third quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company’s stock worth $4,865,000 after acquiring an additional 9,037 shares in the last quarter. Natixis Advisors LLC increased its position in shares of Clorox by 8.3% in the third quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock worth $10,341,000 after acquiring an additional 4,839 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in shares of Clorox by 1.8% in the third quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock worth $117,932,000 after acquiring an additional 13,038 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Price Performance

NYSE CLX opened at $156.52 on Friday. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The stock has a market capitalization of $19.28 billion, a PE ratio of 42.76, a price-to-earnings-growth ratio of 2.62 and a beta of 0.42. The company has a 50 day moving average price of $156.88 and a two-hundred day moving average price of $160.26. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37.

Clorox (NYSE:CLX) last posted its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the firm earned $2.16 earnings per share. As a group, equities analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.12%. The ex-dividend date is Wednesday, April 23rd. Clorox’s dividend payout ratio (DPR) is presently 133.33%.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on CLX. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and lifted their target price for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Wells Fargo & Company lifted their target price on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 4th. Barclays boosted their price objective on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research report on Wednesday, February 5th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research report on Tuesday, February 4th. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $159.62.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.